These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 4042237)

  • 1. Application of solid dispersions of nifedipine with enteric coating agent to prepare a sustained-release dosage form.
    Hasegawa A; Nakagawa H; Sugimoto I
    Chem Pharm Bull (Tokyo); 1985 Apr; 33(4):1615-9. PubMed ID: 4042237
    [No Abstract]   [Full Text] [Related]  

  • 2. Bioavailability and stability of nifedipine-enteric coating agent solid dispersion.
    Hasegawa A; Nakagawa H; Sugimoto I
    Chem Pharm Bull (Tokyo); 1985 Jan; 33(1):388-91. PubMed ID: 4006028
    [No Abstract]   [Full Text] [Related]  

  • 3. Aqueous coating dispersion (pseudolatex) of zein improves formulation of sustained-release tablets containing very water-soluble drug.
    Li XN; Guo HX; Heinamaki J
    J Colloid Interface Sci; 2010 May; 345(1):46-53. PubMed ID: 20129615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on sustained-release dosage forms. III. Preparation of nifedipine suppositories and bioavailability in rabbits.
    Umeda T; Yokoyama T; Ohnishi N; Kuroda T; Kita Y; Kuroda K; Asada S
    Chem Pharm Bull (Tokyo); 1985 Sep; 33(9):3953-9. PubMed ID: 4092295
    [No Abstract]   [Full Text] [Related]  

  • 5. Delayed release film coating applications on oral solid dosage forms of proton pump inhibitors: case studies.
    Missaghi S; Young C; Fegely K; Rajabi-Siahboomi AR
    Drug Dev Ind Pharm; 2010 Feb; 36(2):180-9. PubMed ID: 20070183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time-release compression-coated core tablet containing nifedipine for chronopharmacotherapy.
    Sawada T; Kondo H; Nakashima H; Sako K; Hayashi M
    Int J Pharm; 2004 Aug; 280(1-2):103-11. PubMed ID: 15265551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of poloxamers on nifedipine microparticles prepared by Hot Air Coating technique.
    Pattarino F; Giovannelli L; Bellomi S
    Eur J Pharm Biopharm; 2007 Feb; 65(2):198-203. PubMed ID: 17008076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dissolution mechanism of solid dispersions of nifedipine with enteric coating agents].
    Hasegawa A; Kawamura R; Nakagawa H; Sugimoto I
    Yakugaku Zasshi; 1985 Jun; 105(6):586-92. PubMed ID: 4067824
    [No Abstract]   [Full Text] [Related]  

  • 9. Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine (II): in vivo evaluation.
    Tanaka N; Imai K; Okimoto K; Ueda S; Tokunaga Y; Ibuki R; Higaki K; Kimura T
    J Control Release; 2006 May; 112(1):51-6. PubMed ID: 16545477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The kinetics of nifedipine release from porous hydrophilic matrices and the pharmacokinetics in man.
    Leucuta SE
    Pharmazie; 1988 Dec; 43(12):845-8. PubMed ID: 3247376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro study on capsule formulations of omeprazole containing enteric coated granules.
    Pandey VP; Phanindrudu A; Manavalan R; Livingston J
    Boll Chim Farm; 2002; 141(6):419-22. PubMed ID: 12577509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo evaluation of ofloxacin sustained release pellets.
    Cui Y; Zhang Y; Tang X
    Int J Pharm; 2008 Aug; 360(1-2):47-52. PubMed ID: 18538518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nifedipine gastrointestinal therapeutic system.
    Swanson DR; Barclay BL; Wong PS; Theeuwes F
    Am J Med; 1987 Dec; 83(6B):3-9. PubMed ID: 3503595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preparation of nifidipine pulsatile release tablets].
    Zhang Y; Zhang ZR
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Mar; 35(2):261-3. PubMed ID: 15071935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled release of nifedipine from gelatin microspheres and microcapsules: in vitro kinetics and pharmacokinetics in man.
    Leucuţa SE
    J Microencapsul; 1990; 7(2):209-17. PubMed ID: 2329447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nifedipine di-matrix depot tablets prepared by compression coating for obtaining zero-order release.
    Liu T; Shi Y; Li J; Jiang W; Yin T; Zhang Y; He H; Wang Y; Tang X
    Drug Dev Ind Pharm; 2018 Sep; 44(9):1426-1433. PubMed ID: 29871528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-time predictions of drug release and end point detection of a coating operation by in-line near infrared measurements.
    Gendre C; Boiret M; Genty M; Chaminade P; Pean JM
    Int J Pharm; 2011 Dec; 421(2):237-43. PubMed ID: 21983094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coating of pharmaceuticals by phase separation of cellulose derivatives: preparation and in-vitro release.
    Khalil SH; el-Gamal SS
    Pharmazie; 1973 Jun; 28(6):385-8. PubMed ID: 4726397
    [No Abstract]   [Full Text] [Related]  

  • 19. Development of novel spray coated soft elastic gelatin capsule sustained release formulations of nifedipine.
    Abd El-Sattar Fahmy S; Christensen JM; Ayres JW
    Drug Dev Ind Pharm; 2009 Aug; 35(8):1009-21. PubMed ID: 19274589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained-release pellets of nifedipine using microcrystals combined with MCC-based matrix.
    Ma J; Wang J; Cheng Z; Yin T; Teng H; Xu H; Tang X; Cai C
    Drug Dev Ind Pharm; 2015 Feb; 41(2):307-14. PubMed ID: 24320880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.